CNS Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-2.40
|
0.00
|
2.40
|
100.00%
|
|
2022-09-30
|
-2.40
|
-2.70
|
-0.30
|
-12.50%
|
|
2022-06-30
|
-2.40
|
-2.70
|
-0.30
|
-12.50%
|
|
2022-03-31
|
-3.30
|
-2.10
|
1.20
|
36.36%
|
|
2021-12-31
|
-4.80
|
-3.00
|
1.80
|
37.50%
|
|
2021-09-30
|
-4.87
|
-4.20
|
0.67
|
13.76%
|
|
2021-06-30
|
-3.90
|
-4.50
|
-0.60
|
-15.38%
|
|
2021-03-31
|
-3.60
|
-4.50
|
-0.90
|
-25.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.50
|
|
2021-12-31
|
-16.20
|
|
2020-12-31
|
-5.79
|
|
2019-12-31
|
-0.26
|